Results 1 to 10 of about 345,333 (344)
New England Journal of Medicine, 2018 Aplastic anemia - bone marrow failure (AA) is defined as pancytopenia with hypocellular bone marrow without signs of marrow fibrosis or of presence of abnormal cells. Recent studies showed that most of AA cases might be mediated by immune mechanisms.
Thomas Menter, Alexandar Tzankov
semanticscholar +7 more sources
Pathogenesis of aplastic anemia [PDF]
Hematology, 2019 Aplastic anemia (AA) is a rare and life-threatening bone marrow failure (BMF) that results in peripheral blood cytopenia and reduced bone marrow hematopoietic cell proliferation. The symptoms are similar to myelofibrosis, myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) making diagnosis of AA complicated.
Hong Liu, Li Wang
openaire +4 more sources
Clinical utility of hematological parameters in aplastic anemia [PDF]
Scientific ReportsHematological parameters available on automated hematology analyzers have been shown to be useful indicators for hematological disorders. However, extensive studies especially in aplastic anemia for these indices are sparse.
Lizhong Zhang +4 more
doaj +2 more sources
Haematologica, 2019 Aplastic anemia is a rare but potentially life-threatening disease that may affect older patients. Data regarding the treatment of aplastic anemia in this ageing population remains scarce.
Adrien Contejean +22 more
doaj +2 more sources
Haematologica, 2018 Oligoclonal expansion of CD8+ CD28− lymphocytes has been considered indirect evidence for a pathogenic immune response in acquired aplastic anemia. A subset of CD8+ CD28− cells with CD57 expression, termed effector memory cells, is expanded in several ...
Valentina Giudice +8 more
doaj +2 more sources
Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment
Blood Advances, 2018 : Treatment of severe aplastic anemia has improved significantly over the past 4 decades. This review will summarize the key areas of progress in the use of allogeneic hematopoietic cell transplantation and nontransplant immunosuppressive therapy (IST ...
George E. Georges +2 more
doaj +2 more sources
Incidence of aplastic anemia in Bangkok. The Aplastic Anemia Study Group [PDF]
Blood, 1991 The annual incidence of aplastic anemia in metropolitan Bangkok, Thailand, and its five suburban provinces was prospectively determined. All patients first diagnosed during the period from January through December 1989 who met specific clinical and pathologic criteria were included. Thirty-two cases were identified, yielding an overall incidence of 3.7
David Kaufman +9 more
openaire +5 more sources
Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, 2020 Treatments of aplastic anemia are comprised of supportive therapy and aplastic anemia-specific therapy aimed at restoring hematopoiesis. Supportive therapies include transfusion, G-CSF, and the administration of iron chelation agents, as well as dealing ...
Kensuke Usuki
semanticscholar +2 more sources
Approach to the diagnosis of aplastic anemia.
Blood Advances, 2021 Establishing a diagnosis of aplastic anemia (AA) can be challenging, but it is absolutely critical to appropriate management, especially differentiating between acquired and inherited forms of the disease. The hematology field requires updated diagnostic
A. DeZern, J. Churpek
semanticscholar +1 more source
Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia
Leukemia, 2021 The prevalence and functional impact of somatic mutations in nonleukemic T cells is not well characterized, although clonal T-cell expansions are common.
S. Lundgren +18 more
semanticscholar +1 more source